Australian researchers found promise in the world’s first ever placebo-controlled trial on the effectiveness of cannabis compounds in treating chronic insomnia.
Double blind and placebo-controlled protocols were used, making it the first of its kind to document the use of cannabis compounds in treating chronic insomnia as the primary condition.
“This study represents the most rigorous clinical trial ever undertaken to assess the therapeutic potential of medicinal cannabis to treat the symptoms of chronic insomnia.” – Peter Eastwood, Lead Researcher
During the trial period, 23 volunteers were given either a placebo or dose of a formulation made from the cannabis compounds THC and CBD in the form of an oil administered under the tongue.
Participants were given the option to take a single or double dose, and after two weeks were assessed by a questionnaire called the Insomnia Severity Index (ISI), along with other subjective feedback and information acquired by wrist-based sleep trackers.
Every patient subject to the compound reported more time asleep and greater feelings of rest. Participants who took only single doses reported on average a 26 percent reduction in ISI scores compared to the placebo group, while double dosed patients observed a reduction of 36 percent.
The cannabis formula was made from a combination of THC and CBD, but the exact amounts were not disclosed and thus is referred to simply as ZTL-101.
Via Waking Times
The poet/editor of this website is physically disabled, and lives at a fraction of her nation’s poverty level. Contributions may be made at: https://www.gofundme.com/are-you-a-patron-of-the-arts